Double Your Love. Double Your Impact.
Double Your Love. Double Your Impact.
Help provide 2x the care and support for millions affected by Alzheimer’s and advance research to bring us closer to a cure. Make a gift during our Double the Love 2x Match now.
Donate Now$100 Million Increase for Alzheimer’s and Dementia Research Signed into Law
With the $100 million funding increase now finalized, the total annual federal investment in Alzheimer’s and dementia research will be approximately $3.9 billion. The BOLD funding represents the highest annual investment since the law was enacted, strengthening the nation’s public health response to Alzheimer’s and other dementia in communities across the country.
“By finalizing this increase, our nation’s leaders are choosing progress in the fight against Alzheimer’s and other dementia,” said Robert Egge, Alzheimer’s Association chief public policy officer and AIM president. “This funding helps move science forward and brings us closer to better ways to prevent, detect, treat, and care for dementia.”
The additional NIH funding will support research across the full spectrum of Alzheimer’s and dementia science — from understanding disease mechanisms and identifying biomarkers, to advancing prevention strategies and developing more effective treatments and care approaches. Increased funding for the BOLD Infrastructure for Alzheimer’s Act will further strengthen state and community capacity to reduce risk factors, promote early detection and diagnosis, support caregivers, and improve outcomes for people living with dementia.
This progress was made possible by years of sustained advocacy from people impacted by Alzheimer’s and other dementia, who worked tirelessly to build bipartisan support in Congress. Throughout the year, AIM advocates from all 50 states engaged lawmakers through meetings, emails, phone calls and social media outreach — sharing their personal stories and urging Congress to act. Their voices played a critical role in ensuring Alzheimer’s and dementia research remained a priority throughout the appropriations process.
“Families and advocates have grown bipartisan support in Congress, and it has driven progress against Alzheimer’s and other dementia for more than a decade,” Egge added. “This increase honors those voices and keeps the work moving toward new treatments and a cure.”
More than 7 million Americans are currently living with Alzheimer’s disease, with millions more acting as caregivers or loved ones. As the nation’s population ages, these numbers are expected to grow, underscoring the urgency of sustained and robust federal investment in research and public health infrastructure.
About the Alzheimer's Association
The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.
Alzheimer’s Impact Movement
The Alzheimer's Impact Movement (AIM) is a separately incorporated advocacy affiliate of the Alzheimer's Association. AIM works to develop and advance policies to overcome Alzheimer's disease through increased investment in research, enhanced care and improved support. For more information, visit alzimpact.org.